First Manhattan’s Pliant Therapeutics PLRX Stock Holding History

First Manhattan’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-370,200	Closed	-$6.42M	–	1541
2023 Q3	$6.42M	Hold	370,200	–	–	0.02%	189
2023 Q2	$6.71M	Hold	370,200	–	–	0.02%	183
2023 Q1	$9.85M	Hold	370,200	–	–	0.04%	147
2022 Q4	$7.16M	Hold	370,200	–	–	0.03%	189
2022 Q3	$7.73M	Buy	370,200 +370,000	+185,000%	+$7.08M	0.03%	166
2022 Q2	$1K	Hold	200	–	–	﹤0.01%	1498
2022 Q1	$1K	Hold	200	–	–	﹤0.01%	1545
2021 Q4	$2K	Hold	200	–	–	﹤0.01%	1488
2021 Q3	$3K	Hold	200	–	–	﹤0.01%	1488
2021 Q2	$5K	Hold	200	–	–	﹤0.01%	1391
2021 Q1	$7K	Buy	+200	New	+$6.5K	﹤0.01%	1297

Other funds holding PLRX

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

First Manhattan's PLRX Position: Q4 2023 in Review

First Manhattan sold out of Pliant Therapeutics (PLRX) in Q4 2023, closing a stake of 370,200 shares — an estimated $6.42M sold.

First Manhattan first reported a position in PLRX in Q1 2021 and held it in 11 quarters. The position peaked at $9.85M in Q1 2023. 134 funds tracked by Wall St. Rank hold PLRX as of Q4 2023.

First Manhattan reported no remaining Pliant Therapeutics position as of Q4 2023 after selling out during the quarter.
First Manhattan sold 370,200 Pliant Therapeutics shares in Q4 2023, an estimated $6.42M.
First Manhattan first reported a position in Pliant Therapeutics in Q1 2021 and held it in 11 quarters.
First Manhattan's Pliant Therapeutics position peaked at $9.85M in Q1 2023.
134 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2023.

Based on First Manhattan's 13F filing for Q4 2023, filed 13 Feb 2024.